Earnings calendar

Spyre Therapeutics, Inc. earnings · SYRE

Next earnings: Nov 3 2026 · -0,79 per share expected · 6 analysts

6 of 8 quarters beat the EPS consensus

6/24 · Estimate -0,90 6/24 · Actual -0,86 6/24 9/24 · Estimate -0,80 9/24 · Actual -1,36 9/24 12/24 · Estimate -1,10 12/24 · Actual -0,81 12/24 3/25 · Estimate -0,76 3/25 · Actual -0,74 3/25 6/25 · Estimate -0,73 6/25 · Actual -0,49 6/25 9/25 · Estimate -0,68 9/25 · Actual -0,15 9/25 3/26 · Estimate -0,66 3/26 · Actual -0,74 3/26 6/26 · Estimate -0,71 6/26 · Actual -0,36 6/26
EPS estimate EPS actual
DateQuarterWhen EPS estimateEPS actual Surprise Revenue (USD M) vs a year ago Price reactionNote
Aug 4 2026 Jun/2026 after close -0,71 -0,36 +49.3% — — -0.6% SEC →
May 5 2026 Mar/2026 before open -0,66 -0,74 -12.1% — — +2.7% SEC →
Nov 4 2025 Sep/2025 after close -0,68 -0,15 +77.9% — — -0.6% SEC →
Aug 5 2025 Jun/2025 after close -0,73 -0,49 +32.9% — — -5.4% SEC →
May 8 2025 Mar/2025 after close -0,76 -0,74 +2.6% — — +9.6% SEC →
Feb 27 2025 Dec/2024 after close -1,10 -0,81 +26.4% — — +7.2% SEC →
Nov 7 2024 Sep/2024 after close -0,80 -1,36 -70.0% — — +5.0% SEC →
Aug 7 2024 Jun/2024 after close -0,90 -0,86 +4.4% — — +2.9% SEC →

EPS: earnings per share, the figure the source compares with the analysts' consensus; often adjusted, not the GAAP figure in the press release (the «SEC» link opens the official release). Surprise: how far the actual figure is from the estimate. Reaction: from the close before the announcement to the first close after it; if the time is unknown, from the day before to the day after (2 sessions). Revenue: each quarter's actual figure filed with the SEC (it appears when the company files its 10-Q); there are no estimates, no open source provides them.

Source: Nasdaq (earnings calendar, Zacks consensus) · SEC EDGAR (dates and revenue) · Yahoo (price reaction)

SYRE insider buys and sells (Form 4)

Other companies reporting earnings these days

Sysco Corporation (SYY) · Transdigm Group Incorporated (TDG) · Atlassian Corporation (TEAM) · Bio-Techne Corp (TECH) · Tempus AI, Inc. (TEM) · Teva Pharmaceutical Industries Limited (TEVA) · Millicom International Cellular S.A. (TIGO) · TKO Group Holdings, Inc. (TKO)

This is not investment advice.

Your stocks' earnings, next to your portfolio

In Arvenyx you filter the calendar by the stocks you own and follow, and every stock page shows the last quarters.

Create a free account